Medical Device Packaging Market

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed packaging engineering journals, medical device industry publications, and authoritative health authorities. Key sources included the US Food & Drug Administration (FDA) 21 CFR Part 820 Quality System Regulations and MAUDE database, European Medicines Agency (EMA) Medical Device Regulation (MDR 2017/745), International Organization for Standardization (ISO 11607 series for sterile barrier systems and ISO 13485 quality management), Notified Bodies including TÜV SÜD, BSI Group, and DEKRA certification directories, Advanced Medical Technology Association (AdvaMed), Medical Device Manufacturers Association (MDMA), Institute of Packaging Professionals (IoPP), Flexible Packaging Association (FPA), Healthcare Packaging Consortium, Journal of Medical Packaging, Pharmaceutical & Medical Packaging News, Medical Device and Diagnostic Industry (MD+DI), National Institutes of Health (NIH) PubMed, CDC National Healthcare Safety Network, WHO Global Health Observatory, EU Eurostat Healthcare Statistics, and national medical device regulatory agencies from key markets. These sources were used to collect regulatory compliance data, sterilization validation studies, material safety assessments, packaging failure analysis reports, and sterile barrier system performance standards for plastics, paper & paperboard, metal foils, and glass components across primary, secondary, and tertiary packaging configurations.

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. CEOs, VPs of Operations, regulatory affairs directors, and commercial leaders from medical device packaging converters, raw material suppliers (films, foils, papers, adhesives), and sterilization service providers comprised the supply-side sources. The demand-side sources consist of procurement directors from medical device OEMs (Class I, II, and III devices), regulatory compliance managers, packaging engineers from diagnostic equipment manufacturers, and supply chain executives from contract packaging organizations (CPOs) and hospital purchasing consortia. The primary research validated packaging material adoption trends, confirmed sterilization method compatibility timelines, and garnered insights on sustainability transitions, automated packaging line integration, and validation protocol requirements.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Global market valuation was derived through revenue mapping and sterilization cycle volume analysis. The methodology included:

Identification of 50+ key packaging converters and material suppliers across North America, Europe, Asia-Pacific, and Latin America

Product mapping across plastic resins (PE, PP, PET, PVC), paper & paperboard, aluminum foils, and glass materials for pouches, thermoformed trays, blister packs, clamshells, and rigid containers

Analysis of reported and modeled annual revenues specific to medical device packaging portfolios

Coverage of manufacturers representing 75-80% of global market share in 2024

Extrapolation using bottom-up (procedure volume × packaging unit cost by sterilization method [EtO, gamma, e-beam, steam]) and top-down (converter revenue validation) approaches to derive segment-specific valuations for sterile vs. non-sterile applications